NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)

The summary for the NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
	CFDA Number:	93.853
	CFDA Description:	Extramural Research Programs in the Neurosciences and Neurological Disorders
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PAR-06-005
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Oct 20, 2005
	Creation Date:	Oct 20, 2005
	Original Closing Date for Applications:	Multiple dates, see announcement.
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Oct 02, 2008
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Only United States small business concerns (SBCs) are eligible to submit SBIR applications. A small business concern is one that, at the time of award, for both Phase I and Phase II awards, meets all of the following criteria: 1. Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the US economy, and is organized for profit. 2. Is at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States. 3. Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in 13 C.F.R. Part 121. Business concerns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. Control can be exercised through common ownership, common management, and contractual relationships. The term "affiliates" is defined in greater detail in 13 C.F.R. 121.103. The term "number of employees" is defined in 13 C.F.R. 121.106. A business concern may be in the form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust, or cooperative. Further information may be obtained at http://sba.gov/size, or by contacting the Small Business Administration's Government Contracting Area Office or Office of Size Standards.
Grant Description: - This FOA requests applications using the SBIR Cooperative Agreement (U44) mechanism to provide support for Phase II, and Fast-Track projects that directly address identification and pre-clinical testing of new therapeutics. - Only Aims required for therapy development can be supported in this program. No basic/mechanistic Aims may be included in the research plan. - There is no specific limit on the total funds that will be awarded under this FOA or on the number of awards. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. - This FOA employs the SBIR (U44) cooperative agreement mechanism. Applications may be submitted for support as Phase II or Fast-Track grants. Phase II applicants may request a project period of up to three years and a budget of up to $750,000 total costs per year, or $1 million total costs per year if studies required for IND or IDE filing with the FDA are included. Applicants may request a project period of up to two years and a budget of up $300,000 total costs per year for the Phase I part of a Fast-Track application. - Initial merit review is convened by the NINDS Scientific Review Branch. - Only U.S. small business concerns are eligible to submit SBIR applications. A small business concern is one that, on the date of award, meets ALL of the criteria as described in Section III. I.A. of this announcement. - Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs. The Project Director/Principal Investigator (PD/PI) must have his/her primary employment (more than 50%) with the small business at the time of award and for the duration of the project, which precludes full-time employment elsewhere. - Applicant SBCs may submit more than one application, provided each application is scientifically distinct. - See Section IV.1 for application materials. The application instructions for this Funding Opportunity Announcement (FOA) are located at the following links: - http://grants.nih.gov/grants/funding/424/SF424_RR_Guide_SBIR_STTR.doc (MS Word) - http://grants.nih.gov/grants/funding/424/SF424_RR_Guide_SBIR_STTR.pdf (PDF) - For general information on SF424 (R&R) Application and Electronic Submission, see the following Web sites: - SF424 (R&R) Application and Electronic Submission Information: http://grants.nih.gov/grants/funding/424/index.htm - General information on Electronic Submission of Grant Applications: http://era.nih.gov/ElectronicReceipt/ - Telecommunications for the hearing impaired is available at: TTY 301-451-0088. This funding opportunity will utilize the Small Business Innovation Research (SBIR) U44 cooperative agreement mechanism, but will be run in parallel with two program announcements of identical scientific scope, NINDS Exploratory/Developmental Projects in Translational Research" (http://grants.nih.gov/grants/guide/pa-files/PAR-05-157.html) and NINDS Cooperative Program in Translational Research" (http://grants.nih.gov/grants/guide/pa-files/PAR-05-158.html), that will utilize the exploratory/developmental (R21) grant mechanism and the research project (U01) cooperative agreement mechanism.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PAR-06-005.html http://grants.nih.gov/grants/guide/pa-files/PAR-06-005.html
Grant Announcement Contact: Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email FBOWebmaster@mail.nih.gov FBOWebmaster@mail.nih.gov Webmaster, NIH
Similar Government Grants: • NINDS Research Education Programs for Residents and Fellows in Neurology, Neurosurgery, Neuropatholo...; • Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) In the Epilepsies (R01...; • Spinal Muscular Atrophy (SMA) Biomarker Study (U01); • Limited Competition for Continuation of Induced Pluripotent Stem Cell (iPSC) Resources promoting Tra...; • Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in the Rare Di...; • NINDS Institutional Center Core Grants to Support Neuroscience Research; • Career Development Award to Promote Diversity in Neuroscience Research; • Specialized Program of Translational Research in Acute Stroke; • NINDS Cooperative Program in Translational Research; • NINDS Mentored Research and Clinical Scientist Development Awards in Translational Research